In several 11th five year plan projects 90% of the fund misappropriated.

CWP No. 14537 of 2012, under Articles 226 / 227 of Constitution of India is filled for issuance of a writ of Mandamus or any other writ order or direction, directing the C.B.I. to conduct a detailed and thorough investigation into the financial irregularities and lapses which have taken place at National Institute of Pharmaceutical Education and Research (NIPER), as the CVC on the complaint of the petitioner has failed to hold an inquiry into the matter and thus failed to perform its mandatory duties. 

As there is a close relationship between achieved/ unachieved objectives and financial implications, it is unrealistic to expect that irregularities and lapses has no beneficiary  Details of some research and infrastructure projects where heavy misappropriation took place, are given below:

Scheme Number	Name	Outlay/ Misappropriation
N-05	New Auditorium	Rs.5.50 crores; 100% misapp.No such auditorium constructed. However, expense of Rs.4.22 crores shown in mid-term review report, which is surprising.
N-10	Earth filling and Landscaping	Rs.1.28 crores; >50% misapp. No work done, as per mid-term review report dated 24/4/2010.
N-11	Furniture and Air-conditioning	Rs.4.00 crores; >90% misapp.As per information available, furniture and AC was for new auditorium, which has not been constructed. However expense of Rs.1.81 crores has been shown in mid-term review report dated 24/4/2010.
N-14	New Specialization in Pharmaceutical Management	Rs.1.60 crores;  >90% misapp. No such specialization introduced. 2 new courses introduced in 2010 using existing staff only. Rs.10 lacs released to management department  in 2012 (5th Year).
N-15	Research in Pharmacovigilance and Pharmaco-economics	Rs.2.50 crores; >75% misapprop. Project not included in final list of presentations.
N-17	Setting up of Department of Intellectual Property Rights at NIPER	Rs.2.25 crores;  >90% misapp. No department established at all. Though about Rs.1.5 crores was for hiring and training of manpower, NOT A SINGLE technical person hired. Entire amount misappropriated. Serious shortcoming listed in final report by Project Leader, Dr.Parikshit Bansal
N-19	Cerebral Ischemia/MRI	Rs.5.00 crores;  100% misappr. No work done at all, as per mid-term review dated 24/4/2010.Project not included in final list of presentations.

Scheme Number	Name	Outlay/ Misappropriation
C-05	Pharma Parasitology/ Virology/ Infection Lab	Rs.9.13 crores; >50% misappr. Less funds released.
C-07	Pharma Grid	Rs. 11.06 crores; > 60% misappr. Person who proposed the  project not informed of final approved project, nor given any funds during initial 3 years.
C-11	Nano Technology and Drug Delivery System	Rs.5.25 crores; >40% misappr. Serious shortcomings listed in the final report by Dr.Neeraj Kumar.
C-12	Establishment of Business Development Group at NIPER	Rs.1.75 crores; >75% misapp. No such group established. No final presentation of output under the project made. Project not included in final list of presentations.
C-13	Reference Standard Development	Rs.2.00 crores; >90% misappr. Though Rs.2 crore was taken from the Govt. for making reference standards, not a single reference standard available for industry after project completion.
C-15	Impurity profiling and stability testing facility	Rs.1.02 crores;>90% misappr. No such facility established. No work done, as per mid-term review dated 24/4/2010.